Stephan Kloess

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Point-of-Care Anti-CD19-CAR T-cell Therapy Induces Renal Remission in Refractory Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.

Point-of-Care Anti-CD19-CAR T-cell Therapy Induces Renal Remission in Refractory Myeloperoxidase-Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.

Journal: Kidney international reports
Published: April 16, 2025

Anti-CD19 CAR-T cell therapy for acquired hemophilia A.

Anti-CD19 CAR-T cell therapy for acquired hemophilia A.

Journal: Leukemia
Published: January 09, 2025

Correction to: Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors.

Correction to: Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors.

Journal: Journal of molecular medicine (Berlin, Germany)
Published: December 06, 2023

CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC).

CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC).

Journal: Cancers
Published: May 08, 2023

Low Energy Electron Irradiation Is a Potent Alternative to Gamma Irradiation for the Inactivation of (CAR-)NK-92 Cells in ATMP Manufacturing.

Low Energy Electron Irradiation Is a Potent Alternative to Gamma Irradiation for the Inactivation of (CAR-)NK-92 Cells in ATMP Manufacturing.

Journal: Frontiers in immunology
Published: March 22, 2021

CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation.

CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation.

Journal: Journal for immunotherapy of cancer
Published: September 18, 2020

Harnessing NK Cell Checkpoint-Modulating Immunotherapies.

Harnessing NK Cell Checkpoint-Modulating Immunotherapies.

Journal: Cancers
Published: May 31, 2020

From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment.

From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment.

Journal: Frontiers in immunology
Published: January 15, 2020

Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering.

Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering.

Journal: Human gene therapy methods
Published: April 19, 2019

Preclinical Assessment of Suitable Natural Killer Cell Sources for Chimeric Antigen Receptor Natural Killer-Based "Off-the-Shelf" Acute Myeloid Leukemia Immunotherapies.

Preclinical Assessment of Suitable Natural Killer Cell Sources for Chimeric Antigen Receptor Natural Killer-Based "Off-the-Shelf" Acute Myeloid Leukemia Immunotherapies.

Journal: Human gene therapy
Published: February 09, 2019

Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset.

Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset.

Journal: Frontiers in immunology
Published: September 17, 2018

Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1G93A mouse model of amyotrophic lateral sclerosis.

Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1G93A mouse model of amyotrophic lateral sclerosis.

Journal: Journal of tissue engineering and regenerative medicine
Published: July 25, 2018
Showing 1-12 of 37

Last Updated: 09/26/2026